Ad
The French National Pharmaceutical Academy estimates that the EU imports 80 percent of its 'active pharmaceutical ingredients' - mostly from China and India (Photo: Grumpy-Puddin)

Will coronavirus change EU's pharma supply chain?

The impact of the coronavirus on China and India, two of the world's largest pharmaceutical exporters, has disrupted medicine supply chains worldwide, seeing manufacturing, distribution and trade restrictions, plus short-term scarcities for certain products.

"This crisis has revealed our morbid dependency on China and India as regards pharmaceuticals," the European Commission vice-president Vera Jourova said on Sunday (April 19) in a debate on Czech state television.

"This is some...

To read this story, log in or subscribe

Enjoy access to all articles and 25 years of archives, comment and gift articles. Become a member for as low as €1,75 per week.

Already a member? Login

Author Bio

Elena is EUobserver's editor-in-chief. She is from Spain and has studied journalism and new media in Spanish and Belgian universities. Previously she worked on European affairs at VoteWatch Europe and the Spanish news agency EFE.

The French National Pharmaceutical Academy estimates that the EU imports 80 percent of its 'active pharmaceutical ingredients' - mostly from China and India (Photo: Grumpy-Puddin)

Tags

Author Bio

Elena is EUobserver's editor-in-chief. She is from Spain and has studied journalism and new media in Spanish and Belgian universities. Previously she worked on European affairs at VoteWatch Europe and the Spanish news agency EFE.

Ad

Related articles

Ad
Ad